LAIZI is Tacrolimus ointment, manufactured and marketed by Wansheng Pharmaceutical, which we acquired in July, 2015,indicated for the treatment of local skin immune response for the short-term and non-continuous chronic treatment of moderate to severe atopic dermatitis. LAI ZI is included in the National Medical Insurance Catalogue as a Category B drug.